we do not provide, prescribe, dispense, or arrange access to retatrutide Retatrutide is the most-studied triple agonist in the weight-management research pipeline, and the Phase 2 results drew significant attention
Great quality product
Medical conditions: Rare conditions like ovarian cysts or certain cancers may elevate hCG
However, like all therapies, peptide treatments should be individualized and used under the guidance of a healthcare professional, considering potential risks and benefits
Sources The New England Journal of Medicine: Tirzepatide Once Weekly for the Treatment of Obesity Zepbound Eli Lilly: Zepbound Coverage and Savings for Patients Zepbound Eli Lilly: Zepbound Coverage and Savings for Healthcare Providers Eli Lilly Investors: Lillys tirzepatide delivered up to 22.5% weight loss in adults with obesity or overweight in SURMOUNT-1 Eli Lilly Investors: Tirzepatide demonstrated significant and superior weight loss compared to placebo in two pivotal studies FDA Label: MOUNJARO (Tirzepatide Injection) Medication Guide FDA Label: ZEPBOUND (Tirzepatide Injection) Medication Guide Important Medical Information and Disclaimers Important Current Status Update: On March 19, 2025, the FDA ended enforcement discretion for compounded tirzepatide
Ultimately, the goal is simple: keep residents informed, keep building staff safe, and proactively address emerging issues before they become larger problems, Fiume said
